(1)
Ergasheva Gulshan Tokhirovna. BREAKTHROUGH THERAPIES IN TYPE 2 DIABETES: ADVANCED ROLE OF GLP-1 RECEPTOR AGONISTS AND SGLT2 INHIBITORS. imjrd 2026, 13, 882-885.